Diabetes care: reasons for missing HbA1c measurements in general practice

Debby G Keuken1, Henk J Brouwer, Parad S Keijser

  • 1Department of General Practice, Division of Clinical Methods & Public Health, Academic Medical Center-University of Amsterdam, Amsterdam, Netherlands. d.g.keuken@amc.uva.nl.

BMC Research Notes
|July 16, 2011
PubMed

Insights

Many patients with type 2 diabetes miss glycated haemoglobin (HbA1c) tests, primarily because they are under specialized care. This highlights challenges in diabetes care quality monitoring within primary health centers.

Area of Science:

  • Diabetes Mellitus Research
  • Primary Care Quality Improvement
  • Clinical Audit

Background:

  • Glycated haemoglobin (HbA1c) is a key indicator for assessing diabetes care quality.
  • Complete patient data registration, including HbA1c, is often challenging to achieve.
  • Understanding reasons for missing data is crucial for improving diabetes management.

Purpose of the Study:

  • To investigate the reasons behind missing glycated haemoglobin (HbA1c) measurements in type 2 diabetes patients.
  • To identify factors contributing to incomplete data in electronic medical records within primary care settings.

Main Methods:

  • Retrospective analysis of HbA1c measurements for 1485 type 2 diabetes patients.
  • Data collected from 19 general practitioners across 4 primary care health centers in Amsterdam.
  • Examination of documented reasons for absent HbA1c test results.

Main Results:

  • A significant proportion of patients (23.9%, n=356) had missing HbA1c measurements.
  • The primary reason cited for missing tests was the patient receiving specialized care (50% of cases).
  • General practitioners reported various other reasons for the lack of HbA1c data.

Conclusions:

  • Specialized care status is a major factor contributing to missing HbA1c measurements in primary care.
  • Insights gained can inform strategies to improve data completeness and diabetes care monitoring.
  • Addressing data gaps is essential for accurate quality assessment in diabetes management.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...